Lixte Biotechnology Holdings, Inc. (LIXT) Financials

LIXT Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2023 5.2 million 311736
June 30, 2023 3.1 million 402614
March 31, 2023 4.3 million 249987
Dec. 31, 2022 5.6 million 394786

LIXT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -944389 112106
June 30, 2023 -1.2 million 280060
March 31, 2023 -1.3 million 276980
Dec. 31, 2022 -1.2 million 385391

LIXT Net Income

No data available :(

LIXT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 5.1 million - -
June 30, 2023 2.9 million - -
March 31, 2023 4.1 million - -
Dec. 31, 2022 5.4 million - -

LIXT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 2.1 million
June 30, 2023 1.7 million
March 31, 2023 1.7 million
Dec. 31, 2022 1.7 million

LIXT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 - 132487 534013 -
June 30, 2023 - 427457 862571 -
March 31, 2023 - 189085 1.2 million -
Dec. 31, 2022 - 453620 1.2 million -

LIXT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - -
June 30, 2023 - -
March 31, 2023 - -
Dec. 31, 2022 - -

LIXT

Price: $7.61

52 week price:
0.64
7.61

Earnings Per Share: -1.16 USD

P/E Ratio: -2.21

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 110300

Market Capitalization: 88.0 million

Links: